⌘K

Login Start Free

Home/Filings/4/0001209191-19-034245

4//SEC Filing

ULLIAN ELAINE 4

Accession 0001209191-19-034245

CIK 0000875320other

View on SEC.gov Company Profile

Filed

Jun 3, 8:00 PM ET

Accepted

Jun 4, 4:17 PM ET

Size

5.1 KB

Accession

0001209191-19-034245

Insider Transaction Report

Form 4

Period: 2019-06-01

VERTEX PHARMACEUTICALS INC / MAVRTX

Director

Transactions

Award
Stock Option (Right to Buy)
2019-06-01+6,659→ 6,659 total
Exercise: $168.04Exp: 2029-05-31→ Common Stock (6,659 underlying)

Footnotes (1)

[F1]Fully vested.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1

filerCIK 0001190290

Filing Metadata

Form type: 4
Filed: Jun 3, 8:00 PM ET
Accepted: Jun 4, 4:17 PM ET
Size: 5.1 KB

View on SEC.gov